Video

Institutional Perspectives in Rheumatology: ANCA-associated Vasculitis

Dr. Kenneth J. Warrington led the panel in discussing various topics in rheumatology.

Recently, Kenneth J. Warrington, MD, Mayo Clinic, chaired a panel of rheumatologists to discuss the current state of vasculitis care.

The program, called Institutional Perspectives in Rheumatology: ANCA-associated Vasculitis, is part of HCPLive’s® State of the Science series.

Joining Warrington on the March 22 panel was 2 other rheumatologists from the Mayo Clinic.

Matthew J. Koster, MD, kicked off the program with a discussion on the burden of ANCA-associated vasculitis (AAV). Koster was followed by Tanaz A. Kermani’s, MD, discussion on treatment options.

Koster then returned for a talk on integrating patient care.

Warrington then closed out the webinar with a discussion on novel therapies.

Related Videos
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.